Aragen Life Sciences’ Post

📰📰 As you have seen this week, 2024 looks to be an amazing year for our industry. Here at Nucleus Biologics, we also have some big plans! Navigate over to our NEWS section to stay up to date on the latest, including our recent collaboration agreement with Core Biogenesis. Our blog section also contains interesting industry insights and in-depth analysis of cell culture products and processes, new product releases, and more. #biotech #lifescience #cellculture https://hubs.ly/Q02gHqfj0

📌 Syngene Announces First Quarter Results for FY 2025!   Commenting on the first quarter, Jonathan Hunt, Managing Director and Chief Executive Officer, Syngene International Limited, said, “First quarter performance was broadly flat, in line with our expectations, reflecting the dip in funding for US biotechs that has impacted our sector over the last two years. However, the value of US biotech funding has seen a marked improvement in the first half of 2024. It will take a while for this funding to flow into outsourcing activities and Syngene is in a strong position to capture a significant share of the upturn in biotech spending in the months ahead.”  Read the full press release, link in the comments section 🔗 #Syngene #SyngeneQ1Results #FY25 #Biotech #Pharma

🚀 Exciting News from AbCellera! 🚀 AbCellera Biologics Inc. is making significant strides with their TCE platform and strategic partnerships. They're on track for CTA submissions by Q2 2025! Stay ahead with the latest advancements in biotechnology. Click the link to read more: https://lnkd.in/d2ePEpht #Biotech #Innovation #AbCellera #TCEPlatform 👉 Learn more today!

Where do we stand with cell line development? Check out DDW's Fall 2024 article featuring Frank Gesellchen, Assay Development Manager at Sphere Fluidics! Frank Gesellchen, discusses the rising demand for biologics and how innovative tools like Cyto-Mine® are addressing industry challenges. "Minimizing batch-to-batch variability in cell density, clone stability, and product yield is critical for achieving consistent, high-quality biologics production. By identifying high-expressing clones early with Cyto-Mine®, we significantly reduce development timelines and improve downstream efficiency." He also highlights the impact of automated high-throughput screening (HTS) and the role of single-cell analysis in increasing the precision and reliability of therapeutic protein production. Read the article here to discover how we're shaping the future of biotech with innovative solutions: https://bit.ly/4ee6Rj9 #DrugDiscovery #Microfluidics #BioTech

Resolian Video Series: Chapter 7   Day seven of our video series featuring our CEO Patrick Bennett with Chris Conner from Life Science Marketing Radio.   🔍 "Diverse Analytical Prowess Unveiled"   Unlocking the depths of Resolian's analytical capabilities reveals a remarkable breadth across various specialties. While many labs excel in specific areas, each of Resolian's entities stands out for its comprehensive strength. With extensive experience ranging from immunoassay to LCMS, including small molecules, large molecules, biologics, and oligonucleotides, Resolian covers a spectrum of analytical domains.   🎬 Watch the video here to find out more about the diverse analytical skills at Resolian.   #Resolian #VideoSeries #CompanyCulture #LabInnovation #WatchNow #Bioanalytics #bioanalyticalservices #AnalyticalSciences #ContractResearchOrganization #CRO #biotech #lifescience #pharma #drugdevelopment 🎥

Irrespective of the NGS Platform you are working on, if you have a pipetting intensive Magnetic Bead based Size selection and/or Clean-up step, please let us make your work much easier with the CyBio Felix. The video highlights the ease with reliability and reproducibility associated with automation, #FlexYourFeliX, me thinks 😎

Immunovant (IMVT): Navigating Recent Developments and Market Movements in the Biotech Space This article delves into Immunovant's recent developments, analyzes the resulting share price movement & offers actionable insights for investors #Immunovant #Biotech https://lnkd.in/gdNyUvpq

Not being the tallest myself, I've always held a special place in my heart for the beauty of small things. This might be why Fragment-Based Drug Discovery (FBDD 😍 ) resonates so strongly with me! I'm thrilled to share that Selvita's Project Owner, Aleksandra Bebel, will be participating in the upcoming 9thRSC-BMCS (https://bit.ly/49NNavX). Selvita has a number of exciting FBDD projects where Aleksandra played a key role in X-ray screening of fragments, with my skilled team supporting them with CADD. Our main tools for this work are InfiniSee and SeeSAR (thanks Marcus Gastreich, BioSolveIT), and we're also grateful for the strong support from Selvita's AI Team (kudos to Joerg Wichard and his Team). Whether you're already passionate about FBDD or just curious to learn more, I highly recommend attending the event and connecting with Aleksandra Bebel for a deeper dive into this fascinating field! #drugdiscovery #pharma #biotech #fragmentbased #medicinalchemistry #structuralbiology

The growing demand for adeno-associated viral (AAV) vectors in therapeutic applications emphasizes the need for scalable and more efficient manufacturing methods. However, building a sustainable, flexible system for manufacturing is a challenge many in our industry have yet to master.    In our latest blog, we feature a Q&A with one of our leading upstream vector development managers, featured in BioPharm International's March edition.   Building scalable AAVs that can make it to the clinic and beyond doesn't have to be impossible. Let Silvia Ungari teach you why. Read and learn: https://lnkd.in/gSb9uPAp #advancedtherapies #lifesciences #biopharma #pharma #biotech #cellandGene #CDMO #AGCBio

📢 Attention, time change! May 16th, at 14:40, Stage 5    ✅ "From risk to remedy – Polish biotech's answers to sustain stable drug and diagnostics supply during shortages"  🎤 Join the discussion panel at Impact CEE, where Konstantin Matentzoglu (Polpharma Biologics) alongside Katarzyna Rolle (Polish Academy of Sciences), Dariusz Adamusiński (MedTech Poland), and moderator Joanna Bekker (Polityka Insight) will discuss how collaboration between businesses and science can strengthen supply chains when needed. Don't miss this important discussion! #IMPACTCEE #Innovation #Biotechnology #PolpharmaBiologics